News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
758,077 Results
Type
Article (47406)
Company Profile (343)
Press Release (710310)
Multimedia
Podcasts (151)
Webinars (21)
Section
Business (215166)
Career Advice (2307)
Deals (37574)
Drug Delivery (136)
Drug Development (85136)
Employer Resources (180)
FDA (17135)
Job Trends (15769)
News (364945)
Policy (35201)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2692)
Accelerated approval (33)
Adcomms (33)
Allergies (151)
Alliances (52701)
ALS (179)
Alzheimer's disease (1726)
Antibody-drug conjugate (ADC) (344)
Approvals (17366)
Artificial intelligence (560)
Autoimmune disease (164)
Automation (39)
Bankruptcy (381)
Best Places to Work (11889)
BIOSECURE Act (23)
Biosimilars (204)
Biotechnology (198)
Bladder cancer (159)
Brain cancer (60)
Breast cancer (655)
Cancer (4969)
Cardiovascular disease (431)
Career advice (1947)
Career pathing (41)
CAR-T (297)
CDC (52)
Celiac Disease (2)
Cell therapy (786)
Cervical cancer (36)
Clinical research (72491)
Collaboration (1813)
Company closure (5)
Compensation (1183)
Complete response letters (70)
COVID-19 (2862)
CRISPR (97)
C-suite (890)
Cystic fibrosis (149)
Data (6310)
Decentralized trials (2)
Denatured (44)
Depression (141)
Diabetes (522)
Diagnostics (6860)
Digital health (49)
Diversity (13)
Diversity, equity & inclusion (47)
Drug discovery (269)
Drug pricing (219)
Drug shortages (34)
Duchenne muscular dystrophy (242)
Earnings (93380)
Editorial (65)
Employer branding (21)
Employer resources (160)
Events (122585)
Executive appointments (1021)
FDA (20304)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1520)
Gene editing (209)
Generative AI (49)
Gene therapy (640)
GLP-1 (1090)
Government (4995)
Grass and pollen (7)
Guidances (385)
Healthcare (19404)
HIV (60)
Huntington's disease (46)
IgA nephropathy (87)
Immunology and inflammation (282)
Immuno-oncology (62)
Indications (111)
Infectious disease (3147)
Inflammatory bowel disease (198)
Inflation Reduction Act (14)
Influenza (118)
Intellectual property (256)
Interviews (364)
IPO (17199)
IRA (58)
Job creations (4221)
Job search strategy (1637)
JPM (69)
Kidney cancer (17)
Labor market (86)
Layoffs (610)
Leadership (38)
Legal (8738)
Liver cancer (94)
Longevity (15)
Lung cancer (669)
Lymphoma (383)
Machine learning (43)
Management (62)
Manufacturing (844)
MASH (175)
Medical device (14029)
Medtech (14084)
Mergers & acquisitions (21457)
Metabolic disorders (1384)
Multiple sclerosis (167)
NASH (21)
Neurodegenerative disease (341)
Neuropsychiatric disorders (98)
Neuroscience (3019)
Neurotech (1)
NextGen: Class of 2026 (6784)
Non-profit (4631)
Now hiring (67)
Obesity (675)
Opinion (311)
Ovarian cancer (169)
Pain (218)
Pancreatic cancer (232)
Parkinson's disease (294)
Partnered (34)
Patents (514)
Patient recruitment (502)
Peanut (60)
People (62051)
Pharmaceutical (100)
Pharmacy benefit managers (33)
Phase 1 (22608)
Phase 2 (31783)
Phase 3 (23849)
Pipeline (5371)
Policy (317)
Postmarket research (2730)
Preclinical (9546)
Press Release (68)
Prostate cancer (244)
Psychedelics (53)
Radiopharmaceuticals (293)
Rare diseases (896)
Real estate (6524)
Recruiting (73)
Regulatory (26067)
Reports (52)
Research institute (2493)
Resumes & cover letters (383)
Rett syndrome (27)
RNA editing (18)
RSV (84)
Schizophrenia (160)
Series A (250)
Series B (199)
Service/supplier (14)
Sickle cell disease (100)
Special edition (26)
Spinal muscular atrophy (164)
Sponsored (43)
Startups (3872)
State (2)
Stomach cancer (19)
Supply chain (111)
Tariffs (100)
The Weekly (105)
Vaccines (1073)
Venture capital (94)
Weight loss (462)
Women's health (93)
Worklife (19)
Date
Today (106)
Last 7 days (629)
Last 30 days (2207)
Last 365 days (30980)
2026 (3553)
2025 (31258)
2024 (36349)
2023 (41159)
2022 (52387)
2021 (56922)
2020 (55451)
2019 (48182)
2018 (36451)
2017 (33932)
2016 (33632)
2015 (39468)
2014 (33429)
2013 (28591)
2012 (30666)
2011 (31335)
2010 (29332)
Location
Africa (849)
Alabama (84)
Alaska (7)
Arizona (321)
Arkansas (14)
Asia (45227)
Australia (7009)
California (11437)
Canada (3327)
China (1196)
Colorado (488)
Connecticut (486)
Delaware (343)
Europe (94552)
Florida (1721)
Georgia (359)
Hawaii (3)
Idaho (61)
Illinois (885)
India (69)
Indiana (536)
Iowa (22)
Japan (445)
Kansas (126)
Kentucky (38)
Louisiana (26)
Maine (72)
Maryland (1408)
Massachusetts (8265)
Michigan (328)
Minnesota (636)
Mississippi (5)
Missouri (128)
Montana (32)
Nebraska (28)
Nevada (126)
New Hampshire (79)
New Jersey (3062)
New Mexico (31)
New York (3018)
North Carolina (1534)
North Dakota (8)
Northern California (5567)
Ohio (342)
Oklahoma (22)
Oregon (47)
Pennsylvania (2303)
Puerto Rico (25)
Rhode Island (48)
South America (1225)
South Carolina (67)
South Dakota (1)
Southern California (4454)
Tennessee (177)
Texas (1771)
United States (40779)
Utah (340)
Vermont (1)
Virginia (278)
Washington D.C. (84)
Washington State (930)
West Virginia (4)
Wisconsin (114)
Wyoming (2)
758,077 Results for "china pharma holdings inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
China
Clinical Trials Are Increasingly Going Global—With China a Main Beneficiary
AstraZeneca’s $15 billion pledge to its China operations highlights the country’s advantages. But other regions are also hoping to host more clinical studies.
February 2, 2026
·
8 min read
·
Annalee Armstrong
Press Releases
Ayrmid Appoints ACA Pharma as Exclusive Distributor for Omisirge(R) across Greater China and Southeast Asia
February 9, 2026
·
3 min read
Insights
CRO Boom in APAC Region, With China at the Forefront
The CRO market in the APAC region is thriving, particularly in China, due to intense clinical trial and innovation development, with Western investors and pharma leaning in.
November 19, 2025
·
5 min read
·
Jennifer Smith-Parker
Press Releases
Ascentage Pharma Announces IND Clearance by the China CDE for BTK Degrader APG-3288
February 6, 2026
·
8 min read
Insights
Five Trends That Got Everyone Talking in Pharma and Biotech This Year
In 2025, landmark obesity drug deals, China’s biotech surge, and AI’s deeper integration into pharma operations drove a year of transformation and renewed momentum for life sciences.
November 12, 2025
·
5 min read
·
Jennifer Smith-Parker
Press Releases
China SXT Pharmaceuticals Inc. Announces $10 Million Registered Direct Offering
January 12, 2026
·
3 min read
Press Releases
CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES STRATEGIC INITIATIVE TO APPLY AI TECHNOLOGY ACROSS THE TCM SUPPLY CHAIN
January 16, 2026
·
3 min read
Obesity
Kailera, Hengrui Push Oral GLP-1/GIP Pill to Phase 3 After Clearing Mid-Stage China Study
Kailera will launch a global Phase 2 study of ribupatide this year, while Hengrui will push the asset into Phase 3 in China.
February 10, 2026
·
1 min read
·
Tristan Manalac
China
AstraZeneca Pledges $15B More in Chinese Investments for Cell Therapies, Radiopharma
AstraZeneca has risen as one of pharma’s most prolific investors in China, including a $630 million pledge last week for full rights to AbelZeta’s cell therapy for cancer.
January 29, 2026
·
1 min read
·
Tristan Manalac
China
Pharma Spent More Than $48B in China in H1, Eclipsing Total 2024 Haul
If the trend holds, IQVIA expects 2025 deal volume between Chinese and multinational companies to easily eclipse the 100 agreements signed in 2024.
August 27, 2025
·
2 min read
·
Annalee Armstrong
1 of 75,808
Next
